NASDAQ · Financial Statements
PDS Biotechnology Corporation (PDSB) Financial Statements
$1.38
NASDAQ: PDSB
Market Cap $77.17M
Overview Financials Dividend PDS Biotechnology Corporation most recently reported annual revenue of $0, net profit of $-34.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-21.0M $-42.0M $-43.0M $-36.0M $-32.0M Net Profit $-17.0M $-41.0M $-43.0M $-38.0M $-34.0M EPS $-0.66 $-1.43 $-1.39 $-1.03 $-0.74 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $67.0M $77.0M $59.0M $45.0M $30.0M Total Liabilities $4.0M $33.0M $33.0M $26.0M $21.0M Cash $65.0M $74.0M $57.0M $42.0M $27.0M Borrowings $0 $23.0M $24.0M $22.0M $17.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-12.0M $-26.0M $-34.0M $-35.0M $-28.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $-1.0M $0 $1.0M $0 Net Cash Flow $36.0M $9.0M $-17.0M $-15.0M $-15.0M Free Cash Flow $-12.0M $-26.0M $-34.0M $-35.0M $-28.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.04 EV / EBITDA -2.06 FCF Yield -29.42% Quick Ratio 0.57 Interest Coverage -4.18 Return 1Y -37.11% Return 3Y -85.66% Return 5Y -92.33%
Screens featuring this stock